Amazon targets GLP-1 drug access gap

Amazon is entering the GLP-1 drug market by simplifying the patient experience. Currently, accessing these popular weight-loss medications involves navigating separate relationships with clinicians, pharmacies, and insurers, often leading to complex refill processes and unclear costs. Amazon's One Medical arm has launched a GLP-1 Management Program designed to streamline this entire journey. The program aims to integrate clinical screening, prescription fulfillment, and potentially cost management into a single, more convenient platform for patients seeking these treatments.